2014 OIS@ASCRS Executive Report
BOSTON — The Third Annual Ophthalmology Innovation Summit (OIS@ASCRS) took place on April 24, just prior to the 2014 annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS). The purpose of this conference is to support innovation by facilitating deal-flow and business partnerships between CEOs of young companies, investors, corporate executives, physicians, and academic scientists in the field of ophthalmology. A newly expanded agenda format, which more closely resembled the flagship OIS@AAO meeting, was met with rave reviews in Boston.
The program included a total of seventeen innovative companies that are treating conditions in either the anterior or posterior chambers of the eye. First time OIS presenters were EyeSonix, Anew Optics, RPS- Rapid Pathogen Screening, pSivida, CXLO, TearLab, TearScience, and Panoptes Pharma while the returnees included ClarVista Medical, PowerVision, i-Optics, WaveTec Vision Systems, Clarity Medical Systems, Avedro, Mimetogen Pharmaceuticals, Eleven Biotherapeutics, and Ocular Therapeutix.
Read the full executive report:
SHARE THIS ARTICLE WITH YOUR COLLEAGUES:
RECOMMENDED FOR YOU
OIS@ASRS Reporter’s Notebook: Three Things Learned at OIS@ASRS About What Funders Want, Going Global, and AI